SEC Form 4 · accession 0001209191-15-031793
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mikael Dolsten
Director
Period of report
Mar 31, 2015
Accepted (ET)
Apr 2, 2015 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory stock option (right to buy)F1 | $30.61 | Mar 31, 2015 | A | 20,000 | A | — | Mar 30, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option was granted on March 31, 2015. The shares underlying this option vest as to one-third (1/3) of the shares on March 31, 2016 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.